Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boege, F.
Right arrow Articles by Helmreich, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boege, F.
Right arrow Articles by Helmreich, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 18, 9040-9049, 06, 1988

Role of glycosylation for beta 2-adrenoceptor function in A431 cells

F Boege, M Ward, R Jurss, M Hekman and EJ Helmreich
Department of Physiological Chemistry, University of Wurzburg Medical School, Federal Republic of Germany.

A431 cells incubated with tunicamycin (0.15 micrograms/ml) for 40 h under conditions where incorporation of [3H] leucine into protein was inhibited less than 10% expressed mainly a beta-receptor species of about Mr 40,000 which was ascribed to the nonglycosylated form of the beta-receptor of about Mr 75,000 found in normal A431 cells by photoaffinity labeling. However, the tunicamycin-treated cells expressed the same number of specific beta 2-receptor-binding sites as untreated cells. Moreover, the aglycoreceptors had the same ligand binding properties as beta-adrenoceptors from control cells; but, functional tests of the receptor from tunicamycin-treated cells in reconstituted lipid vesicles showed that receptors from tunicamycin- treated cells had lost coupling efficiency. The coupling defect was at the receptor level since control experiments indicated that the other components of the signal transmission chain from beta-adrenoceptor to adenylate cyclase, the stimulatory regulatory GTP-binding protein of adenylate cyclase and adenylate cyclase, were fully functional. Homologous desensitization in tunicamycin-treated cells was characterized by export from the cell surface and sequestration of about the same number of beta-adrenoceptors as in normal desensitized cells but without further reduction of hormonally stimulated adenylate cyclase below the low level already attained in nondesensitized tunicamycin-treated cells. This was explained by assuming that the receptors removed in the course of homologous desensitization from the surface of tunicamycin-treated cells were already nonfunctional. Thus, beta-adrenergic desensitization in tunicamycin-treated cells is characterized by the functional disengagement of receptor removal and loss of adenylate cyclase activity.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Oostendorp, D. S. Postma, H. Volders, H. Jongepier, H. F. Kauffman, H. M. Boezen, D. A. Meyers, E. R. Bleecker, S. A. Nelemans, J. Zaagsma, et al.
Differential Desensitization of Homozygous Haplotypes of the {beta}2-Adrenergic Receptor in Lymphocytes
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 322 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. G. Cumbay and V. J. Watts
Novel Regulatory Properties of Human Type 9 Adenylate Cyclase
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 108 - 115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Chotani, S. Flavahan, S. Mitra, D. Daunt, and N. A. Flavahan
Silent alpha 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1075 - H1083.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. B. Izevbigie and W. G. Bergen
{beta}-Adrenergic Agonist Hyperplastic Effect Is Associated with Increased Fibronectin Gene Expression and Not Mitogen-Activated Protein Kinase Modulation in C2C12 Cells
Experimental Biology and Medicine, March 1, 2000; 223(3): 302 - 309.
[Abstract] [Full Text]


Home page
JEMHome page
T. Schulte, R. Kurrle, M. Rollinghoff, and A. Gessner
Molecular Characterization and Functional Analysis of Murine Interleukin 4 Receptor Allotypes
J. Exp. Med., November 3, 1997; 186(9): 1419 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. da Silva Correia and R. J. Ulevitch
MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor
J. Biol. Chem., January 11, 2002; 277(3): 1845 - 1854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement